158 related articles for article (PubMed ID: 32346476)
1. Cross-reactivity between
Cancelliere N; Iglesias I; Ayuga Á; Enrique Miranda E
Biomed Rep; 2020 Jun; 12(6):326-332. PubMed ID: 32346476
[No Abstract] [Full Text] [Related]
2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity between Parietaria species using the major rParj1 and rParj2 allergens.
Bonura A; Artale A; Marino M; Amoroso S; Marcucci F; Geraci D; Colombo P
Allergy Asthma Proc; 2006; 27(5):378-82. PubMed ID: 17063667
[TBL] [Abstract][Full Text] [Related]
4. Identification of cross-reactive and genuine Parietaria judaica pollen allergens.
Stumvoll S; Westritschnig K; Lidholm J; Spitzauer S; Colombo P; Duro G; Kraft D; Geraci D; Valenta R
J Allergy Clin Immunol; 2003 May; 111(5):974-9. PubMed ID: 12743560
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.
Sharma S; Panzani RC; Gaur SN; Ariano R; Singh AB
Int Arch Allergy Immunol; 2005 Feb; 136(2):103-12. PubMed ID: 15650307
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity between Parietaria judaica and Parietaria officinalis.
Corbi AL; Pelaez A; Errigo E; Carreira J
Ann Allergy; 1985 Feb; 54(2):142-7. PubMed ID: 3970390
[TBL] [Abstract][Full Text] [Related]
9. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
[TBL] [Abstract][Full Text] [Related]
10. Role of carbohydrate moieties in cross-reactivity between different components of Parietaria judaica pollen extract.
Mucci N; Liberatore P; Federico R; Forlani F; Di Felice G; Afferni C; Tinghino R; De Cesare F; Pini C
Allergy; 1992 Aug; 47(4 Pt 2):424-30. PubMed ID: 1280917
[TBL] [Abstract][Full Text] [Related]
11. A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2.
Arilla MC; González-Rioja R; Ibarrola I; Mir A; Monteseirín J; Conde J; Martínez A; Asturias JA
Clin Exp Allergy; 2006 Jan; 36(1):87-93. PubMed ID: 16393270
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever.
Ortolani C; Pastorello EA; Incorvaia C; Ispano M; Farioli L; Zara C; Pravettoni V; Zanussi C
Allergy; 1994 Jan; 49(1):13-21. PubMed ID: 8198235
[TBL] [Abstract][Full Text] [Related]
13. The allergens of Parietaria.
Colombo P; Bonura A; Costa M; Izzo V; Passantino R; Locorotondo G; Amoroso S; Geraci D
Int Arch Allergy Immunol; 2003 Mar; 130(3):173-9. PubMed ID: 12660421
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica.
García-Sellés J; Pascual A; Funes E; Pagán JA; López JD; Negro JM; Hernández J
Allergol Immunopathol (Madr); 2003; 31(2):63-9. PubMed ID: 12646120
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to Parietaria officinalis and Parietaria judaica pollen allergens in a Spanish population.
Dreborg S; Basomba A; Einarsson R
Allergol Immunopathol (Madr); 1986; 14(6):499-508. PubMed ID: 3825837
[TBL] [Abstract][Full Text] [Related]
16. Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts.
Ibarrola I; Sanz ML; Gamboa PM; Mir A; Benahmed D; Ferrer A; Arilla MC; Martínez A; Asturias JA
Clin Exp Allergy; 2004 Feb; 34(2):303-9. PubMed ID: 14987312
[TBL] [Abstract][Full Text] [Related]
17. [Pollinosis caused by Parietaria. Clinical observations in Northern Sardinia and botanical and allergic considerations on P. officinalis L. and P. judaica L. (P. diffusa Mert. and Koch)].
Atzei AD; Vargiu G
Boll Ist Sieroter Milan; 1984 Sep; 63(4):366-77. PubMed ID: 6518087
[TBL] [Abstract][Full Text] [Related]
18. Allergy to Parietaria officinalis pollen.
Cvitanović S
Croat Med J; 1999 Mar; 40(1):42-8. PubMed ID: 9933896
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of asthma and severity of allergic rhinitis comparing 2 perennial allergens: house dust mites and Parietaria judaica pollen.
Sala-Cunill A; Bartra J; Dalmau G; Tella R; Botey E; Raga E; Valero A;
J Investig Allergol Clin Immunol; 2013; 23(3):145-51. PubMed ID: 23967752
[TBL] [Abstract][Full Text] [Related]
20. Parietaria pollinosis in an Atlantic area: clinical and palynological data.
Vidal C; Dopazo A; Aira MJ
J Investig Allergol Clin Immunol; 2001; 11(2):107-11. PubMed ID: 11642568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
